COPD

News

Verona cues up filings for COPD drug after it aces phase 3 t...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next

News

Respira Labs' wearable device listens for lung diseases

US company Respira Labs has developed a device worn on the chest that uses tiny speakers and microphones to project sound into the lungs and listen for signals that could indicate serious l

Views & Analysis

Kaia Health gets $75m for digital solution to strains and pa...

Kaia Health has just announced a $75 million funding round for its technology, aimed at improving musculoskeletal (MSK) and chronic obstructive pulmonary disease (COPD) care.

News

Red spine and vertebral column of a human skeleton

Kaia Health raises $75m for digital musculoskeletal disease ...

Kaia Health has raised a further $75m to expand its AI-based treatment for Musculoskeletal (MSK) and chronic obstructive pulmonary disease (COPD).

News

Hikma shares rally after US launch of Advair generic resumes

Shares in Hikma have rallied as it resumed the launch of its generic Advair Diskus in the US, after clearing up a final piece of bureaucracy with the FDA.

News